Idexx Laboratories (IDXX) EBITDA Margin (2009 - 2026)
Idexx Laboratories (IDXX) posted EBITDA Margin of 38.35% for Q2 2026, up 1.51 percentage points from 36.85% a year earlier and up 3.27 percentage points from the prior quarter.
Powered by 
Analysis
Idexx Laboratories (IDXX) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Idexx Laboratories was 35.42%, up 0.92 percentage points year-over-year; for FY2025, it was 34.97%, up 2.69 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +5.77 percentage points (FY2020 to FY2025).
- In prior years, Idexx Laboratories' EBITDA Margin was 32.28% in FY2024 (-0.82 pp), 33.11% in FY2023 (+3.09 pp), 30.01% in FY2022 (-2.23 pp) and 32.24% in FY2021 (+3.03 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q3 2009.
- On a year-over-year basis, EBITDA Margin increased in seven of the last eight quarters, with an average year-over-year change of +1.75 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2023, with a gain of 10.26 percentage points; the weakest was Q2 2022, with a drop of 10.38 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 35.09% (Q1 2026), 32.49% (Q4 2025) and 35.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 35.10% |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 39.16% |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn | 38.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.35% |
| Mar 31, 2026 | 35.09% |
| Dec 31, 2025 | 32.49% |
| Sep 30, 2025 | 35.42% |
| Jun 30, 2025 | 36.85% |
| Mar 31, 2025 | 35.11% |
| Dec 31, 2024 | 30.95% |
| Sep 30, 2024 | 34.65% |
| Jun 30, 2024 | 29.49% |
| Mar 31, 2024 | 34.11% |
| Dec 31, 2023 | 30.51% |
| Sep 30, 2023 | 33.23% |
| Jun 30, 2023 | 34.34% |
| Mar 31, 2023 | 34.30% |
| Dec 31, 2022 | 30.81% |
| Sep 30, 2022 | 32.48% |
| Jun 30, 2022 | 24.08% |
| Mar 31, 2022 | 32.86% |
| Dec 31, 2021 | 28.32% |
| Sep 30, 2021 | 31.15% |
API Access
Idexx Laboratories EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IDXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();